Forkhead box proteins: tuning forks for transcriptional harmony.
The DOI matches its Crossref record; 198 of the 199 references it cites were found in a registry or an index.
Abstract
Forkhead box (FOX) proteins are multifaceted transcription factors that are responsible for fine-tuning the spatial and temporal expression of a broad range of genes both during development and in adult tissues. This function is engrained in their ability to integrate a multitude of cellular and environmental signals and to act with remarkable fidelity. Several key members of the FOXA, FOXC, FOXM, FOXO and FOXP subfamilies are strongly implicated in cancer, driving initiation, maintenance, progression and drug resistance. The functional complexities of FOX proteins are coming to light and have established these transcription factors as possible therapeutic targets and putative biomarkers for specific cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been suggested that crosstalk between RB and mitogenic AKT signaling pathways play a key role in the quiescence to senescence switch by regulating overlapping functions of Forkhead transcription factors, FOXO3a and FOXM1 (Eijkelenboom and Burgering, 2013; Lam et al., 2013; Imai et al., 2014).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Lam et al., 2013
Citations
Cites
2 retracted
Wang, Z., Banerjee, S., Kong, D., Li, Y., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1265 · Cited by 245
RetractedBao, B., Wang, Z., Ali, S., Kong, D., Banerjee, S., Ahmad, A., Li, Y., Azmi, A. S., Miele, L., & Sarkar, F. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23150 · Cited by 206
RetractedComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,173
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Pioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
Cited by
Items 201–300 of 693
Mechanism of forkhead transcription factors binding to a novel palindromic DNA site
Li, J., Dai, S., Chen, X., Liang, X., Qu, L., Jiang, L., Guo, M., Zhou, Z. M., Wei, H., Zhang, H., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab086 · Cited by 39
Regulation of Wnt Signaling by FOX Transcription Factors in Cancer
Koch, S. (2021) · Cancers · doi:10.3390/cancers13143446 · Cited by 42
Insulin-like Growth Factor 1 Signaling in Mammalian Hearing
García-Mato, Á., Cervantes, B., Murillo‐Cuesta, S., la Rosa, L. R., & Varela‐Nieto, I. (2021) · Genes · doi:10.3390/genes12101553 · Cited by 41
“Both FOXO3 and FOXM1 modulate the activity of the cyclindependent kinase inhibitor p27Kip1, but with opposing effects: while FOXO3 promotes p27Kip1 transcription, leading to cell cycle arrest, FOXM1 blocks nuclear localization of p27Kip1 and enhances its degradation, promoting cell proliferation [30,59].”
BackgroundLaphanuwat, P., Likasitwatanakul, P., Sittithumcharee, G., Thaphaengphan, A., Chomanee, N., Suppramote, O., Ketaroonrut, N., Charngkaew, K., Lam, E. W. ‐., Okada, S., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.214726 · Cited by 43
“Cyclin D1 is a cell cycle regulatory protein, which is amplified and overexpressed in a large number of human cancers (Sukov et al., 2009; Musgrove et al., 2011; Lee et al., 2016).”
BackgroundSelf-citationChen, L., Wu, M.-Y., Ji, C., Yuan, M., Liu, C., & Yin, Q. (2019) · IUBMB Life · doi:10.1002/iub.2166 · Cited by 36
Gao, F., & Tian, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s212702 · Cited by 37
“Forkhead box K (FOXK) family is a subgroup of the Forkhead transcription factors, known to regulate multiple biological processes,(4) including cell cycle progression, apoptosis, differentiation, metabolism, survival and senescence.(5)”
BackgroundLinking Autism Risk Genes to Disruption of Cortical Development
García-Forn, M., Boitnott, A., Akpinar, Z., & Rubeis, S. D. (2020) · Cells · doi:10.3390/cells9112500 · Cited by 37
Planarian stem cells sense the identity of the missing pharynx to launch its targeted regeneration
Bohr, T. E., Shiroor, D. A., & Adler, C. E. (2021) · eLife · doi:10.7554/elife.68830 · Cited by 35
“Mammalian homologs of FoxA were the first identified ‘pioneer’ transcription factors, characterized by their ability to engage closed chromatin and drive organogenesis (Hsu et al., 2015; Iwafuchi-Doi and Zaret, 2016; Lam et al., 2013; Zaret and Mango, 2016).”
BackgroundChesnokov, M. S., Halasi, M., Borhani, S., Arbieva, Z. H., Shah, B. N., Oerlemans, R., Khan, I., Camacho, C. J., & Gartel, A. L. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03978-0 · Cited by 36
Li, B., Teng, C., Yu, H., Jiang, X., Xing, X., Jiang, Q., Lin, C., Zhao, Z., Zhang, R., & He, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.002 · Cited by 36
Cao, H., Chu, X., Wang, Z., Guo, C., Shao, S., Xiao, J. Y., Zheng, J., & Zhang, D. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.068 · Cited by 34
Thaler, S., Thiede, G., Hengstler, J. G., Schad, A., Schmidt, M., & Sleeman, J. P. (2014) · International Journal of Cancer · doi:10.1002/ijc.29404 · Cited by 35
“These observations also provide a mechanistic explanation for the down regulation of ERα by Bortezomib, because Foxo3A inhibits ERα expression (29) and recruits chromatin remodeling proteins such as histone deacetylases to promoters to which it binds (38), which may account for the observation that Bortezomib induces…”
BackgroundLi, C., Zhang, K., Chen, J., Chen, L., Wang, R., & Chu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.14015 · Cited by 38
“More than fifty five or fifty forkhead proteins have been identified in mammals or humans genome, respectively, and they are further classified into 19 subgroups (FOXA to FOXS) basing on sequence homology inside and outside the forkhead domain [3, 4].”
BackgroundNew therapeutics based on emerging concepts in pulmonary fibrosis
Sontake, V., Gajjala, P. R., Kasam, R. K., & Madala, S. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1552262 · Cited by 34
“Forkhead box (Fox) proteins are a family of ‘winged-helix’ DNA-binding domains (DBDs) containing transcription factors that regulate the expression of an array of genes involved in embryonic development and adult tissue homeostasis [44].”
BackgroundThe untold stories of the speech gene, the FOXP2 cancer gene
Herrero, M. J., & Gitton, Y. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.169 · Cited by 34
“Most of these results are in agreement with previous references [63,75,78].”
BackgroundResultFoxm1 regulates cardiomyocyte proliferation in adult zebrafish after cardiac injury
Zuppo, D. A., Missinato, M. A., Santana‐Santos, L., Li, G., Benos, P. V., & Tsang, M. (2023) · Development · doi:10.1242/dev.201163 · Cited by 33
FOXO3a and Posttranslational Modifications Mediate Glucocorticoid Sensitivity in B-ALL
Consolaro, F., Ghaem‐Maghami, S., Bortolozzi, R., Zona, S., Khongkow, M., Basso, G., Viola, G., & Lam, E. W. ‐. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0127 · Cited by 33
“M Mol Cancer Res; 13(12) December 2015 Molecular Cancer Research1586 www.aacrjournals.org Mol Cancer Res; 13(12) December 2015 1587 phase transition, including cyclin B, Aurora B, and FOXM1 (2), and this may explain the G2–”
BackgroundInfluentialSelf-citationЗолотаренко, А. Д., Chekalin, E., Mezentsev, A. V., Kiseleva, L., Gribanova, E., Mehta, R., Baranova, A. V., Tatarinova, T. V., Пирузян, Э. С., & Bruskin, S. A. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.97 · Cited by 33
“31 We also found 294 DEG-associated TFs not identi fi ed by Swindell et al. 25 Sixty-six of them were identi fi ed by cisExpress as well as by MetaCore (Figure 3 and Supplementary Table S10).”
BackgroundNakao, K., Minato, N., & Üemoto, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55651-0 · Cited by 34
Sugawara, T., & Sakamoto, K. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518001563 · Cited by 36
“For example, humans possess approximately fifty members of the FOX transcription factors((21,22)).”
BackgroundFoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer
PELLEGRINO, M. A., Rizza, P., Donà, A., Nigro, A., Ricci, E. D., Fiorillo, M., Perrotta, I. D., Lanzino, M., Giordano, C., Bonofiglio, D., et al. (2019) · Cancers · doi:10.3390/cancers11121858 · Cited by 32
“Increasing interest in FoxO3a is emerging in the oncologic research field since its inhibition is sufficient to make cancer cells resistant to numerous conventional and novel anticancer therapeutics [21].”
BackgroundInfluentialAlasiri, G. A., Jiramongkol, Y., Trakansuebkul, S., Ke, H.-L., Mahmud, Z., Intuyod, K., & Lam, E. W. ‐. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110932 · Cited by 40
Self-citationFOXA1 is a determinant of drug resistance in breast cancer cells
Kumar, U., Ardasheva, A., Mahmud, Z., Coombes, R. C., & Yagüe, E. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-06068-5 · Cited by 41
Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis
Saavedra-García, P., Nichols, K., Mahmud, Z., Fan, L. Y.-N., & Lam, E. W. ‐. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.012 · Cited by 33
“FOXM1 and FOXO3 also antagonise the transcriptional activity of each other by competing for the same binding sites on common target genes (Gomes et al., 2013; Lam et al., 2013).”
Self-citationFOXP1 haploinsufficiency: Phenotypes beyond behavior and intellectual disability?
Myers, A., du Souich, C., Yang, C. L., Borovik, L., Mwenifumbo, J. C., Rupps, R., Study, C., Lehman, A., & Boerkoel, C. F. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38462 · Cited by 33
Wang, L., Wang, J., Jin, T., Zhou, Y., & Chen, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.118 · Cited by 33
FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors
Vereczkei, A., Barta, C., Mägi, A., Farkas, J., Eisinger, A., Király, O., Belik, A. A., Griffiths, M. D., Székely, A., Sasvári‐Székely, M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050690 · Cited by 36
“Forkhead transcription factors belong to one of the major transcription factor families in eukaryotes and contribute to development, immunity, metabolism, and cell cycle control [97].”
Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme.
Robertson, E., Perry, C., Doherty, R. E., & Madhusudan, S. (2015) · PubMed · Cited by 31
FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
Yu, C., Yu, S., Shi, L., Wang, S., Li, Z.-X., Wang, Y., Sun, C., & Liang, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7223 · Cited by 31
“FoxM1 has also been demonstrated to serve essential roles in tumor angiogenesis, invasion and metastasis (20,21).”
Understanding the perspectives of forkhead transcription factors in delayed wound healing
Rajendran, N. K., Kumar, S. S. D., Houreld, N. N., & Abrahamse, H. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0484-0 · Cited by 32
Lv, C., Zeng, Q., Qi, L., Wang, Y., Li, J., Sun, H., Du, L., Hao, S., Li, G., Feng, C., et al. (2024) · Antioxidants · doi:10.3390/antiox13081004 · Cited by 33
“As a nuclear transcription factor, FOXO3a can induce autophagy and apoptosis after nuclear translocation [24].”
FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors
Briest, F., Berg, E. G., Grass, I., Freitag, H., Kaemmerer, D., Lewens, F., Christen, F., Arsenić, R., Altendorf-Hofmann, A., Kunze, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3600 · Cited by 30
“It is considered a key regulator of the G2/M transition of the cell cycle and of the mitotic spindle integrity by regulation of cyclin A and B, cdc25B, aurora A and B kinases, survivin, PLK1, SKP2, CENPB and CENPF/A/B, and degradation of p21 and p27 [3, 4, 6-13].”
BackgroundXu, Z., Yang, Y. Y., Li, B., Li, Y., Xia, K., Yang, Y., Li, X., Wang, M., Li, S., & Wu, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0629-3 · Cited by 32
SETD1A Promotes Proliferation of Castration-Resistant Prostate Cancer Cells via FOXM1 Transcription
Liu, Y., Jin, M., Park, S. J., Seo, S., & Jeong, K. W. (2020) · Cancers · doi:10.3390/cancers12071736 · Cited by 32
“Given that FOXM1 is known as a key molecule that controls the cell cycle process [30], and our pathway analysis revealed that”
BackgroundATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer
Nam, A., Yoon, J., Jin, M.-H., Bang, J., Oh, K.-S., Seo, H.-R., Kim, J.-M., Kim, T., & Oh, D. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.029 · Cited by 31
Moutabian, H., Radi, U. K., Saleman, A. Y., Adil, M., Zabibah, R. S., Chaitanya, M., Saadh, M. J., Jawad, M. J., Hazrati, E., Bagheri, H., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154789 · Cited by 35
GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer
Su, W., Li, S., Chen, X., Yin, L., Ma, P., Ma, Y., & Su, B. (2016) · Oncotarget · doi:10.18632/oncotarget.13879 · Cited by 30
“The FOXO family members, FOXO1, FOXO3 and FOXO4, are ubiquitously expressed transcription factors that function as tumor suppressors through inhibiting the expression of genes promoting proliferation, survival or de-differentiation [22, 23].”
BackgroundCosimo, E., Tarafdar, A., Moles, M. W., Holroyd, A. K., Malik, N., Catherwood, M. A., Hay, J., Dunn, K. M., Macdonald, A. M., Guichard, S. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2036 · Cited by 31
“One target of mTORC2-AKT–mediated signaling is the FOXO family of transcription factors that play a pivotal role in a multitude of cellular homeostatic processes in specific cell contexts in response to a plethora of environmental stimuli including nutrients, insulin and growth factors (21, 41).”
BackgroundWNT5A: a double-edged sword in colorectal cancer progression
Tufail, M., & Wu, C. (2023) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2023.108465 · Cited by 31
FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Ackermann, S., Kocak, H., Hero, B., Ehemann, V., Kahlert, Y., Oberthuer, A., Roels, F., Theißen, J., Odenthal, M., Berthold, F., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-840 · Cited by 29
“Members of the Fox subfamily P share several characteristics that are atypical among Fox proteins: their Forkhead domain is located near the carboxy-terminal region and they contain leucine zipper motifs that promote FoxP homo- and heterodimerization and thus highly selective, tissue- or cell-type specific activity [6…”
BackgroundChen, X., Liu, X., Li, Q.-H., Lu, B., Xie, B., Ji, Y., & Zhao, Y. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02801-2 · Cited by 29
“The upregulation and activation of FOXM1 can lead to a variety of tumor-associated phenotypes such as cell proliferation, tumor stem cells, drug resistance, invasion, metastasis, and angiogenesis [30–33], which have been reported as top-level gene expression biomarkers with poor prognosis [34].”
BackgroundWagatsuma, A., Shiozuka, M., Takayama, Y., Hoshino, T., Mabuchi, K., & Matsuda, R. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2608-7 · Cited by 32
“The following gene-specific primers were used: Bcl2, growth arrest-and DNA-damage-inducible proteins 45 alpha (GADD45a), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), p21WAF1/Cip1, (Real-Time PCR Primer and Probe Database; http://www.medgen.ugent.be/rtprimerdb/), caspase-3 [22], caspase-9 [23], survivin [24], myog…”
BackgroundMathew, D., Drury, J. A., Valentijn, A., Vasieva, O., & Hapangama, D. K. (2015) · Human Reproduction · doi:10.1093/humrep/dev307 · Cited by 31
Ahn, H., Kim, H., Rehman, A., Kim, Y., Sim, J., Choi, D., Paik, S. S., Shin, S., Kim, D., & Jang, K. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx132 · Cited by 29
“The forkhead O (FoxO) subclass is one of the largest subgroups of Fox proteins and includes FoxO1, FoxO3, FoxO4, and FoxO6.(4) FoxO proteins regulate a wide spectrum of biological processes, including differentiation, cell cycle progression, DNA damage repair, and apoptosis.”
BackgroundNicolau‐Neto, P., Costa, N. M. D., Santos, P. T. D. S., Gonzaga, I. M., Ferreira, M. A. D. S., Guaraldi, S., Moreira, M. Â. M., Seuánez, H. N., Brewer, L., Bergmann, A. K., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24621 · Cited by 29
“In this way, activation of the PIK3/ AKT signaling pathway inhibits FOXO3 and indirectly induces FOXM1 activity [19].”
BackgroundPazdrowski, J., Gornowicz‐Porowska, J., Kaźmierska, J., Krajka‐Kuźniak, V., Polańska, A., Masternak, M. M., Szewczyk, M. P., Golusiński, W., & Dańczak‐Pazdrowska, A. (2024) · Reports of Practical Oncology & Radiotherapy · doi:10.5603/rpor.100775 · Cited by 28
“FoxOs belong to a family of transcriptional regulators characterized by a conserved DNA-binding domain termed the forkhead box [39].”
BackgroundAhn, H., Sim, J., Rehman, A., Chung, M. S., Paik, S. S., Oh, Y., Park, C. K., & Jang, K. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.4.390 · Cited by 28
“Deregulation of these kinases induces loss of FoxO3a activity by promoting the nuclear export which retains it as inactive protein in the cytoplasm (6).”
BackgroundInfluentialDNA Damage Response and Cell Cycle Regulation in Pluripotent Stem Cells
Chen, A. C. H., Peng, Q., Fong, S. W., Lee, K. C., Yeung, W. S. B., & Lee, Y. L. (2021) · Genes · doi:10.3390/genes12101548 · Cited by 29
CELLULAR SENESCENCE IMPLICATED IN SEPSIS-INDUCED MUSCLE WEAKNESS AND AMELIORATED WITH METFORMIN
Chen, J., Chen, X. Y., Cong, X. X., Wang, S., Xu, S. B., Sun, Y. T., Zhou, Y., Zheng, L., & Huang, M. (2023) · Shock · doi:10.1097/shk.0000000000002086 · Cited by 31
Yasir, M., Park, J., & Chun, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015173 · Cited by 29
“These 19 sub-groups, designated from FOXA to FOXS, are categorized based on both sequence homology within and outside the forkhead domain [134].”
BackgroundA FOXM1 related long non-coding RNA contributes to gastric cancer cell migration
Cai, H., Chen, J., He, B., Li, Q., Li, Y., & Gao, Y. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2421-3 · Cited by 28
“Deregulation of FOXM1 affects tumor initiation, progression, EMT, metastasis, angiogenesis, and drug resistance [27].”
BackgroundFoxO6 inhibits cell proliferation in lung carcinoma through up-regulation of USP7
HU, H.-J., Zhang, L., Wang, Z., & GUO, X.-X. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3362 · Cited by 28
“The role of FOXO1 in tumor cell proliferation has been well documented (6).”
Qin, Y., Gong, W., Zhang, M., Wang, J., Tang, Z., & Quan, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102084 · Cited by 28
“Forkhead box (FOX) proteins are a superfamily of transcription factors which share a highly conserved DNA-binding domain (the forkhead box or winged helix domain) control a variety of biological processes, including metabolism, differentiation, proliferation and apoptosis [3].”
BackgroundActivated Mutant p110α Causes Endometrial Carcinoma in the Setting of Biallelic Pten Deletion
Joshi, A. R., Miller, C. A., Baker, S. J., & Ellenson, L. H. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.12.019 · Cited by 28
“Nuclear FoxO1 is a transcription factor activating expression of cell cycle inhibitors like p27 and p21, while repressing cyclins D1 and D2.(30) Activated Akt (as a result of Pten loss) phosphorylates FoxO1, leading to nuclear export, inhibiting its transcriptional activity and thus promoting cell proliferation and bl…”
InfluentialThe Function of FoxK Transcription Factors in Diseases
Yu, M., Yu, H., Mu, N., Wang, Y., Ma, H., & Yu, L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.928625 · Cited by 27
“Based on sequence homology, members of the mammalian FOX family can be further divided into 19 subfamilies, namely FoxA to FoxS (Lam et al., 2013).”
BackgroundComputational tools for inferring transcription factor activity
Hecker, D., Lauber, M., Ardakani, F. B., Ashrafiyan, S., Manz, Q., Kersting, J., Hoffmann, M., Schulz, M. H., & List, M. (2023) · PROTEOMICS · doi:10.1002/pmic.202200462 · Cited by 33
The Sclerotinia sclerotiorum FoxE2 Gene Is Required for Apothecial Development
Wang, L., Liu, Y., Liu, J., Zhang, Y., Zhang, X., & Pan, H. (2016) · Phytopathology · doi:10.1094/phyto-08-15-0181-r · Cited by 27
Expression of forkhead box transcription factor genes Foxp1 and Foxp2 during jaw development
Cesario, J. M., Almaidhan, A. A., & Jeong, J. (2016) · Gene Expression Patterns · doi:10.1016/j.gep.2016.03.001 · Cited by 32
“They play important roles in a wide variety of biological processes, such as development, carcinogenesis, metabolism, and immunity (Hannenhalli and Kaestner, 2009; Jackson et al., 2010; Lam et al., 2013).”
BackgroundSUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells
de Moraes, G. N., Ji, Z., Fan, L. Y.-N., Yao, S. J., Zona, S., Sharrocks, A. D., & Lam, E. W. ‐. (2018) · Oncogenesis · doi:10.1038/s41389-018-0038-6 · Cited by 29
Self-citationTuli, H. S., Aggarwal, V., Tuorkey, M. J., Aggarwal, D., Parashar, N. C., Varol, M., Savla, R., Kaur, G., Mittal, S., & Sak, K. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105142 · Cited by 27
Bévant, K., Desoteux, M., Angenard, G., Pineau, R., Caruso, S., Louis, C., Papoutsoglou, P., Sulpice, L., Gilot, D., Zucman‐Rossi, J., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1866 · Cited by 27
“001 and fold change >2) included wellknown TGFβ target genes such as Bcl2 modifying factor (BMF), collagen type I alpha 1 chain (COL1A1), plateletderived growth factor subunit A (PDGFA), SKIlike protooncogene (SKIL) and TGFBI (Supporting Table S2), but also novel candidates, including FOXS1, a transcription factor of…”
BackgroundInfluentialWang, B., Zhang, X., Wang, W., Zhu, Z., Tang, F., Wang, D., Liu, X., Zhuang, H., & Xiao-ling, Y. A. N. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157126 · Cited by 26
Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background
Poh, B. M., Koso, H., Momota, H., Komori, T., Suzuki, Y., Yoshida, N., Ino, Y., Todo, T., & Watanabe, S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz067 · Cited by 29
The Role of Forkhead Box Proteins in Acute Myeloid Leukemia
Gurnari, C., Falconi, G., Bellis, E. D., Voso, M. T., & Fabiani, E. (2019) · Cancers · doi:10.3390/cancers11060865 · Cited by 29
“Despite the high sequence conservation of the forkhead domain, FOX proteins may exert different roles in the fine regulation of downstream genes, acting as repressors or activators of gene expression [14].”
BackgroundSuppression of epithelial differentiation by Foxi3 is essential for molar crown patterning
Jussila, M., Aalto, A., Navarro, M. S., Shirokova, V., Balic, A., Kallonen, A., Ohyama, T., Groves, A. K., Mikkola, M. L., & Thesleff, I. (2015) · Development · doi:10.1242/dev.124172 · Cited by 25
“Foxi3 belongs to the superfamily of Forkhead box transcription factors that act as transcriptional activators, repressors, pioneer factors or chromatin modifiers (Benayoun et al., 2011; Lam et al., 2013).”
BackgroundSachini, N., Arampatzi, P., Klonizakis, A., Nikolaou, C., Makatounakis, T., Lam, E. W. ‐., Kretsovali, A., & Papamatheakis, J. D. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12486 · Cited by 27
“FOXO3 directly binds to FOXM1 promoter to repress its expression but also antagonizes FOXM10s transcriptional output by competitively binding to the same target gene promoters (Lam et al., 2013).”
BackgroundMethodSelf-citationA Review of the Regulatory Mechanisms of N-Myc on Cell Cycle
Li, H., Dong, L., Jin, M.-J., Li, Q.-Y., Wang, X. Q., Jia, M., Song, J., Zhang, S., & Yuan, S. (2023) · Molecules · doi:10.3390/molecules28031141 · Cited by 27
Lam, E. W. ‐., & Gomes, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00305 · Cited by 25
Self-citationOverexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer
Zhang, H., Zhong, H., Li, L., Ji, W., & Zhang, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4875 · Cited by 25
“FOXM1 is a proliferation-associated transcription factor with important roles in cell proliferation, differentiation and apoptosis (21).”
STAT 3 promotes tumour progression in glioma by inducing FOXP 1 transcription
Sun, X., Wang, J., Huang, M., Chen, T., Chen, J., Zhang, F., Zeng, H., Xu, Z., & Ke, Y. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13837 · Cited by 26
“FOX proteins mediate cell‐division cycle, cell viability, differentiation and apoptosis.(28) FOXP1 serves as both potential oncogene and tumour suppressor due to its distinguishing expression levels in diverse tumour types.”
BackgroundBourgeois, B., Spreitzer, E., Platero-Rochart, D., Paar, M., Zhou, Q., Usluer, S., de Keizer, P. L. J., Burgering, B. M. T., Sánchez-Murcia, P. A., & Madl, T. (2025) · Nature Communications · doi:10.1038/s41467-025-60844-9 · Cited by 23
“FOXO4 is a member of the FOX family of transcription factors, which comprises more than 50 members distributed across 19 sub-classes (FOXA to FOXS) 25,26 .”
Wu, J., Wu, Y., Chen, S., Guo, Q., Shao, Y., Liu, C., Lin, K., Wang, S., Zhu, J. W., Chen, X., et al. (2024) · Oncogene · doi:10.1038/s41388-024-02943-3 · Cited by 27
“Through a literature review, it was found that the FOX gene family plays an important role in the occurrence and development of various tumours [33, 34].”
Dai, J. Y., Tapsoba, J. D. D., Buas, M. F., Onstad, L., Levine, D., Risch, H. A., Chow, W., Bernstein, L., Ye, W., Lagergren, J., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0507 · Cited by 28
“The FOXP1 gene encodes a member of the Forkhead box (FOX) family of transcription factors, which share an evolutionarily conserved “winged-helix” DNA binding domain and function as versatile regulators of a wide range of biological processes, including development and cancer (43-45).”
BackgroundReyes, M. E., Ma, J., Grove, M. L., Ater, J. L., Morrison, A. C., & Hildebrandt, M. A. T. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.07.020 · Cited by 26
Lin, C.-H., Lee, H., Chang, W., Lee, F., Chen, L.-C., Lu, L., & Lin, Y. (2020) · Cancers · doi:10.3390/cancers12092690 · Cited by 24
“The forkhead box (FOX) family consists of various tissue and cell type-specific transcription regulators with a conserved winged-helix DNA-binding domain (DBD) or forkhead domain [6].”
BackgroundLim, J., Koh, V., Tan, J. S. Y., Tan, W.-J., Thike, A., & Tan, P. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3296-4 · Cited by 25
“Mesenchymal forkhead 1 (Foxc2) belongs to the forkhead box (FOX) family [30].”
BackgroundJi, Z., Li, Y., Liu, S. X., & Sharrocks, A. D. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1281 · Cited by 28
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
Marrocco, I., Romaniello, D., Vaknin, I., Garcia, D. D., Oren, R., Uribe, M. L., Nataraj, N. B., Ghosh, S., Eilam, R., Salame, T., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013144 · Cited by 25
“FOXM1 is negatively regulated by FOXO3a and competes for the same target genes (Lam et al, 2013).”
FOX transcription factors are common regulators of Wnt/β-catenin–dependent gene transcription
Moparthi, L., & Koch, S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104667 · Cited by 26
“FOX proteins comprise one of the largest transcription factor families, with 44 main family members in humans that are subdivided into 19 classes (A through S) based on sequence similarity (7 – 9).”
BackgroundCancer-free aging: Insights from Spalax ehrenbergi superspecies
Lagunas‐Rangel, F. A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.06.004 · Cited by 25
Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation
Aimjongjun, S., Mahmud, Z., Jiramongkol, Y., Alasiri, G. A., Yao, S. J., Yagüe, E., Janvilisri, T., & Lam, E. W. ‐. (2019) · BMC Cancer · doi:10.1186/s12885-019-6308-7 · Cited by 23
Self-citationLi, J., Ma, W., Cheng, X., Zhang, X., Xie, Y., Ji, Z., & Wu, S. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108363 · Cited by 26
Shi, Y., Meng, X., Xu, Y., & Tian, X. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14753 · Cited by 26
Adam, R. M., & DeGraff, D. J. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.06.006 · Cited by 23
“[43] Lam EW, Brosens JJ, Gomes AR, Koo CY.”
BackgroundConsolaro, F., Basso, G., Ghaem‐Maghami, S., Lam, E. W. ‐., & Viola, G. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3139 · Cited by 23
“FOXM1 is a member of the Forkhead family of transcription factors, previously known as Trident (in mouse), HFH-11 (in human), WIN or INS-1 (in rat), MPP-2 (partial human cDNA) and FKHL-16 (1).”
BackgroundSelf-citationGuo, Z., Huang, J., Wang, Y., Liu, X., Li, W., Yao, J., Li, S., & Hu, W. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00547 · Cited by 22
MicroRNAs as master regulators of FOXO transcription factors in cancer management
Rani, M., Kumari, R., Singh, M., Devi, A., Bansal, P., Siddiqi, A., Alsahli, M. A., Almatroodi, S. A., Rahmani, A. H., & Rizvi, M. M. A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121535 · Cited by 22
Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis
Liu, K., Gao, Q., Jia, Y., Wei, J., Chaudhuri, S. M., Wang, S., Tang, A., Mani, N. L., Iyer, R., Cheng, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110592 · Cited by 27
“37–39 Therefore, this study links three important CSCs genes teaming together to maintain an optimal BCSCs pool.”
Mao, Y., Hou, B., Shan, L., Sun, X., & Wang, L. (2021) · Placenta · doi:10.1016/j.placenta.2021.01.002 · Cited by 25
Spatiotemporal expression and regulation of FoxO1 in mouse uterus during peri-implantation period
Adıgüzel, D., Sahin, P., Kuşçu, N., Özkavukçu, S., Bektas, N. I., & Çelik-Özenci, Ç. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216814 · Cited by 22
Zhu, X., Lu, K., Cao, L., Hu, Y., Yin, Y., & Cai, Y. (2020) · Cancer Management and Research · doi:10.2147/cmar.s270825 · Cited by 21
Circular RNA circBFAR promotes glioblastoma progression by regulating a miR‐548b/FoxM1 axis
Li, C., Guan, X., Jing, H., Xiao, X., Jin, H., Xiong, J., Ai, S., Wang, Y., Su, T., Sun, G., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101307r · Cited by 22
Hou, C.-Y., Ma, C.-Y., Lin, Y.-J., Huang, C., Wang, H., & Yuh, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012100 · Cited by 22
“We hypothesize that two effects were involved: FOXOs are considered tumor suppressors due to their ability in regulating cell cycle arrest, apoptosis, differentiation, DNA damage repair, senescence, and scavenging of reactive oxygen species [61].”
BackgroundZHANG, M., Qingli, X., YAN, S., Li, Z., Yan, W., & Jia, X. (2016) · Oncology Reports · doi:10.3892/or.2016.4651 · Cited by 21
Potent anti‐myeloma activity of the TOPK inhibitor OTS514 in pre‐clinical models
Stefka, A. T., Johnson, D. C., Rosebeck, S., Park, J., Nakamura, Y., & Jakubowiak, A. J. (2019) · Cancer Medicine · doi:10.1002/cam4.2695 · Cited by 22
Wu, W., Lin, J., Pan, C., Chan, T., Liu, C.-L., Wu, W., Sheu, J. J., Yeh, B., Huang, S. K., Jhung, J.-Y., et al. (2019) · Theranostics · doi:10.7150/thno.39018 · Cited by 23
“Among 4 mammalian FOXO members (FOXO1, -3, -4, -6), FOXO3 has a predominant role in controlling cancer development [24].”
BackgroundFOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells
Usami, M., Kikuchi, S., Takada, K., Ono, M., Sugama, Y., Arihara, Y., Hayasaka, N., Nakamura, H., Ikeda, Y., Hirakawa, M., et al. (2019) · Pancreas · doi:10.1097/mpa.0000000000001462 · Cited by 22
KLF2 induces the senescence of pancreatic cancer cells by cooperating with FOXO4 to upregulate p21
Yuedi, D., Houbao, L., Lu, P., Hui, W., Min, T., & Dexiang, Z. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111784 · Cited by 21
SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis
Li, Z., Li, H., Chen, J., Luo, H., Zeng, J., Yao, Y., & Duan, M.-S. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105797 · Cited by 21
Berghausen, E. M., Janssen, W., Vantler, M., Gnatzy-Feik, L., Krause, M., Behringer, A., Joseph, C. G., Zierden, M., ten Freyhaus, H., Klinke, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136939 · Cited by 22
“Nuclear exclusion of FoxO enhances transcription of cyclins and reduces transcription of the CDK inhibitor p27Kip1 (39, 41, 42).”
Background
Metadata
- Authors
- Lam, E. W.-F., Brosens, J. J., Gomes, A. R., & Koo, C.-Y.
- Affiliations
- Hammersmith Hospital (GB)
- University Hospital Coventry (GB)
- Corresponding author
- Lam, Eric W.-F.
- Venue
- Nature Reviews Cancer
- Published
- 2013-06-24
- Volume
- 13
- Issue
- 7
- Pages
- 482-495
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2076174368
- Cited by
- 684
- References
- 199
- Citations by year
- 2026: 20 · 2025: 45 · 2024: 52 · 2023: 65 · 2022: 67 · 2021: 70 · 2020: 57 · 2019: 64 · 2018: 56 · 2017: 56 · 2016: 51 · 2015: 53 · 2014: 24 · 2013: 2
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK (12011)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- forkhead transcription factor, FoxA, FOXO, FoxP, gene expression regulation, cancer, therapeutic target, biomarkers, drug resistance, signal integration
- MeSH terms
- Antineoplastic Agents, Humans, Neoplasms, Forkhead Transcription Factors, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.